{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:55:19Z","timestamp":1791262519602,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373733"],"award-info":[{"award-number":["82373733"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110512","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:20:05Z","timestamp":1789168805000},"page":"110512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of non-conjugated Biaryl amide URAT1 inhibitors as potent Uricosuric agents"],"prefix":"10.1016","volume":"182","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110512_bb0005","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1038\/s41598-022-18361-y","article-title":"Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics","volume":"12","author":"Qin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110512_bb0010","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41598-018-22570-9","article-title":"Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China","volume":"8","author":"Song","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110512_bb0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.110512_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1791120","article-title":"Drug-induced hyperuricemia: multi-pathway regulation, causative drugs, and individualized management strategies","volume":"17","author":"Xiong","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110512_bb0025","doi-asserted-by":"crossref","first-page":"1219 e1217","DOI":"10.1016\/j.amjmed.2016.06.041","article-title":"Association between gout and incident type 2 diabetes mellitus: a retrospective cohort study","volume":"129","author":"Tung","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bioorg.2026.110512_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.106727","article-title":"Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update","volume":"146","author":"Johnson","year":"2026","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.bioorg.2026.110512_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","volume":"80","author":"Borghi","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.bioorg.2026.110512_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.795082","article-title":"Effect of urate-lowering therapy on the progression of kidney function in patients with asymptomatic hyperuricemia: A systematic review and Meta-analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110512_bb0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bioorg.2026.110512_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-025-21643-5","article-title":"Conducting genetic epidemiology research on hyperuricaemia and gout in an indigenous community in Guam - a feasibility study","volume":"25","author":"Paulino","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bioorg.2026.110512_bb0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/gucdd2020016","article-title":"Regulation of urate homeostasis by membrane transporters","volume":"2","author":"Takada","year":"2024","journal-title":"Gout, Urate, and Crystal Deposition Disease"},{"key":"10.1016\/j.bioorg.2026.110512_bb0060","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1038\/s41467-025-60480-3","article-title":"Molecular basis of the urate transporter URAT1 inhibition by gout drugs","volume":"16","author":"Suo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110512_bb0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.bioorg.2026.110512_bb0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11926-012-0240-z","article-title":"Regulation of uric acid excretion by the kidney","volume":"14","author":"Lipkowitz","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bioorg.2026.110512_bb0075","doi-asserted-by":"crossref","first-page":"2427181","DOI":"10.1080\/0886022X.2024.2427181","article-title":"Establishment and optimization of a novel mouse model of hyperuricemic nephropathy","volume":"46","author":"Wang","year":"2024","journal-title":"Ren. Fail."},{"key":"10.1016\/j.bioorg.2026.110512_bb0080","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41422-024-01023-1","article-title":"Transport mechanism and structural pharmacology of human urate transporter URAT1","volume":"34","author":"Dai","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2026.110512_bb0085","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41467-025-56843-5","article-title":"Mechanisms of urate transport and uricosuric drugs inhibition in human URAT1","volume":"16","author":"Guo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110512_bb0090","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/jacsau.4c01188","article-title":"Structural basis for inhibition of urate reabsorption in URAT1","volume":"5","author":"Fan","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.bioorg.2026.110512_bb0095","doi-asserted-by":"crossref","unstructured":"Liu, Y.-f.; Hao, Z.-s.; Guo, X.; Sun, S.-t.; Wang, M.-x.; Zhang, M.-q.; Chen, Y.-y.; Sun, J.-y.; Liu, C. Discovery of novel nuciferine-based URAT1 inhibitors for hyperuricemia: synthesis, biological evaluation, and computational insights. Med. Chem. Res. 2025, 35, 203\u2013214.","DOI":"10.1007\/s00044-025-03510-5"},{"key":"10.1016\/j.bioorg.2026.110512_bb0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature748","article-title":"Netrin-1-mediated axon outgrowth requires deleted in colorectal cancer-dependent MAPK activation","volume":"417","author":"Forcet","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110512_bb0105","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1038\/s41467-025-61226-x","article-title":"Molecular mechanism of drug inhibition of URAT1","volume":"16","author":"Yu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110512_bb0110","article-title":"Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update","volume":"57","author":"Cicero","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bioorg.2026.110512_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102241","article-title":"Emerging strategies for treating gout","volume":"65","author":"Huddleston","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110512_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174291","article-title":"A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: current therapeutic options and potential applications","volume":"907","author":"Song","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110512_bb0125","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/17425255.2023.2287477","article-title":"Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout","volume":"19","author":"Hou","year":"2023","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110512_bb0130","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1124\/dmd.117.077818","article-title":"Metabolic epoxidation is a critical step for the development of Benzbromarone-induced hepatotoxicity","volume":"45","author":"Wang","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2026.110512_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118459","article-title":"Benzoheterocyclic analogues of dotinurad as orally efficacious human urate transporter 1 inhibitors: design, synthesis, structure-activity relationships, and pharmacokinetic studies","volume":"303","author":"Zhang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110512_bb0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.tiv.2017.05.013","article-title":"The catechol-O-methyltransferase inhibitors tolcapone and entacapone uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells","volume":"42","author":"Grunig","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bioorg.2026.110512_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154256","article-title":"Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3","volume":"103","author":"Yong","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2026.110512_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2026.130620","article-title":"Design, synthesis, and biological evaluation of pyridine-triazole derivatives as URAT1 inhibitors with potential application in hyperuricemia and gout","volume":"136","author":"Hu","year":"2026","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110512_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118998","article-title":"Creation of an adequate animal model of hyperuricemia (acute and chronic hyperuricemia); study of its reversibility and its maintenance","volume":"268","author":"Dhouibi","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2026.110512_bb0160","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.metabol.2016.05.009","article-title":"Serum uric acid and mortality in chronic kidney disease: A systematic review and meta-analysis","volume":"65","author":"Xia","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.bioorg.2026.110512_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108312","article-title":"Design, synthesis, and biological evaluation of novel artemisinin-based HDAC inhibitors with antitumor and antimalarial activities","volume":"157","author":"He","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110512_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2026.130608","article-title":"Design, synthesis, and Lead optimization of novel Quinazoline-based FLT3 inhibitors with potent anti-acute myelogenous leukemia activity","volume":"136","author":"Liu","year":"2026","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:30:48Z","timestamp":1791261048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S0045206826010485"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110512","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of non-conjugated Biaryl amide URAT1 inhibitors as potent Uricosuric agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110512"}}